Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).


YUMUK P., TURHAL N., Gumus M. , HATABAY N., TURKEN O., OZKAN A., ...More

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 22
  • City: Louisiana
  • Country: United States Of America